St a r t a f re e a s s e s s m e nt a t
n oz i n . c o m /n ova
PROTECT EVERY PATIENT
SM
*Outcomes reported by actual customers. Your results may vary. References: nozin.com/clinical-outcomes. Nozin
®
Nasal Sanitizer
®
antiseptic is for nasal decolonization. ©2023 Global Life
Technologies Corp. All rights reserved. Made in USA. Nozin
®
, Nasal Sanitizer
®
, Popswab
®
, Protect Every Patient
SM
, and NOVA
SM
are trademarks of Global Life Technologies Corp. Other trademarks
are property of their respective owners. Nozin
®
Nasal Sanitizer
®
antiseptic is an OTC topical drug. No claim is made that it has an eff ect on any specific disease. Patent nos.: nozin.com/patents.
REDUCE RISK OF AVOIDABLE INFECTIONS,
EXCESS LENGTH OF STAY, AND READMISSIONS
Nasal colonization is a primary risk factor for healthcare
associated infections (HAIs). The new patient safety paradigm
is to make universal nasal decolonization the standard of care,
without using antibiotics. This is our Protect Every Patient
SM
service mission to help you prevent HAIs and lower costs.
In published studies, hospitals using Nozin NOVA
SM
programs
powered by Nozin
®
Nasal Sanitizer
®
antiseptic report up
to 100% reduction* in BSIs, SSIs, and significant savings in
unreimbursed treatment expense. Learn more about how
we can help. Start with a no cost risk assessment today.
